期刊
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
卷 42, 期 7, 页码 E203-E216出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.122.315499
关键词
cholesterol; hypercholesterolemia; leucine repetition; lipoproteins; metabolism
资金
- Basque Government [IT1264-19]
- Instituto de Salud Carlos III: CIBERCV
- FIS [PI19/0069]
- Fundacion Biofisica Bizkaia
- Programa de especializacion de Personal Investigador Doctor en la UPV/EHU (2019) 2019-2020
- PIF (2017-2018)
- PIF (2019-2020)
- Gobierno Vasco
This study extensively characterized the activities of L8 and L11 variants located in the signal peptide through in vitro experiments. It was found that the L11 variant enhances intracellular degradation of LDLr, which may lead to inefficient LDLr transport and LDLr degradation, resulting in mild hypercholesterolemia.
Background: PCSK9 (Proprotein convertase subtilisin/kexin type 9) regulates LDL-C (low-density lipoprotein cholesterol) metabolism by targeting LDLr (LDL receptor) for lysosomal degradation. PCSK9 gain-of-function variants cause autosomal dominant hypercholesterolemia by reducing LDLr levels, the D374Y variant being the most severe, while loss-of-function variants are associated with low LDL-C levels. Gain-of-function and loss-of-function activities have also been attributed to variants occurring in the PCSK9 signal peptide. Among them, L11 is a very rare PCSK9 variant that seems to increase LDL-C values in a moderate way causing mild hypercholesterolemia. Methods: Using molecular biology and biophysics methodologies, activities of L8 and L11 variants, both located in the leucine repetition stretch of the signal peptide, have been extensively characterized in vitro. Results: L8 variant is not associated with increased LDLr activity, whereas L11 activity is increased by approximate to 20% compared with wt PCSK9. The results suggest that the L11 variant reduces LDLr levels intracellularly by a process resulting from impaired cleavage of the signal peptide. This would lead to less efficient LDLr transport to the cell membrane and promote LDLr intracellular degradation. Conclusions: Deletion of a leucine in the signal peptide in L8 variant does not affect PCSK9 activity, whereas the leucine duplication in the L11 variant enhances LDLr intracellular degradation. These findings highlight the importance of deep in vitro characterization of PCSK9 genetic variants to determine pathogenicity and improve clinical diagnosis and therapy of inherited familial hypercholesterolemia disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据